
EU regulators recommend Pfizer/BioNTech’s Covid-19 vaccine for authorization
The European Union drugs regulator has recommended authorizing the Pfizer/BioNTech Covid-19 vaccine for use, paving the way for the first phase of the bloc’s mass vaccination program to begin later this week. In a closed-door meeting in Amsterdam on Monday, the European Medicines Agency (EMA) granted the Pfizer/BioNTech vaccine a conditional marketing authorization, green lighting
Continue Reading